Blackrock Neurotech launches Axon-R non-invasive AR BCI headset with Cognixion — broadening BCI beyond implants
Summary
Blackrock Neurotech partnered with Cognixion in May 2025 to distribute the Axon-R — a non-invasive, AR-enabled BCI headset for research and assistive applications — broadening Blackrock's portfolio beyond implanted Utah Arrays. The Axon-R combines EEG-based neural signal acquisition with AR display and eye-tracking, enabling hands-free computer control for patients with motor impairments without surgery. The launch represents Blackrock's first non-invasive consumer-accessible product and leverages Cognixion's existing AAC (augmentative and alternative communication) software ecosystem.
Why it matters
Blackrock Neurotech — the company that has supplied Utah Arrays for every major academic BCI program for 20 years — launching a non-invasive consumer product signals the market is broadening from research implants to accessible assistive technology. The Axon-R gives Blackrock a product that can reach thousands of patients immediately while their MoveAgain implantable BCI advances through regulatory clearance.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial